Initial observations:
* Judging from Annual Leave payment - I hope PR enjoyed his extended summer in a place like the Amalfi coast.
* No list of patents which is what you’d expect in a bio.
* No value ascribed to any patent apart from their respiratory one, which is the least developed.
* After a year, no closer on refloating an EPS scheme but from commentary, they got the message.
* TGA PA dead and buried. Wonder why?
Ann: 2023 Annual Report and Appendix 4E, page-25
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28174 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |